Literature DB >> 26080368

Cytokine-Mediated Loss of Blood Dendritic Cells During Epstein-Barr Virus-Associated Acute Infectious Mononucleosis: Implication for Immune Dysregulation.

Archana Panikkar1, Corey Smith2, Andrew Hislop3, Nick Tellam2, Vijayendra Dasari2, Kristin A Hogquist4, Michelle Wykes2, Denis J Moss2, Alan Rickinson3, Henry H Balfour5, Rajiv Khanna2.   

Abstract

Acute infectious mononucleosis (IM) is associated with altered expression of inflammatory cytokines and disturbed T-cell homeostasis, however, the precise mechanism of this immune dysregulation remains unresolved. In the current study we demonstrated a significant loss of circulating myeloid and plasmacytoid dendritic cells (DCs) during acute IM, a loss correlated with the severity of clinical symptoms. In vitro exposure of blood DCs to acute IM plasma resulted in loss of plasmacytoid DCs, and further studies with individual cytokines showed that exposure to interleukin 10 could replicate this effect. Our data provide important mechanistic insight into dysregulated immune homeostasis during acute IM.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  acute infection; anti-viral immunity; cytokines; dendritic cells; herpesvirus; immune dysregulation; immune regulation; virus

Mesh:

Substances:

Year:  2015        PMID: 26080368     DOI: 10.1093/infdis/jiv340

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation.

Authors:  M S Gilardini Montani; R Santarelli; M Granato; R Gonnella; M R Torrisi; A Faggioni; M Cirone
Journal:  Autophagy       Date:  2018-10-23       Impact factor: 16.016

2.  Plasmacytoid dendritic cells respond to Epstein-Barr virus infection with a distinct type I interferon subtype profile.

Authors:  Cornelia Gujer; Anita Murer; Anne Müller; Danusia Vanoaica; Kathrin Sutter; Emilie Jacque; Nathalie Fournier; Jens Kalchschmidt; Andrea Zbinden; Riccarda Capaul; Andrzej Dzionek; Philippe Mondon; Ulf Dittmer; Christian Münz
Journal:  Blood Adv       Date:  2019-04-09

3.  The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events.

Authors:  Samantha K Dunmire; Jennifer M Grimm; David O Schmeling; Henry H Balfour; Kristin A Hogquist
Journal:  PLoS Pathog       Date:  2015-12-01       Impact factor: 6.823

4.  Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.

Authors:  Rachel J Abbott; Annette Pachnio; Isabela Pedroza-Pacheco; Alison M Leese; Jusnara Begum; Heather M Long; Debbie Croom-Carter; Andrea Stacey; Paul A H Moss; Andrew D Hislop; Persephone Borrow; Alan B Rickinson; Andrew I Bell
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

5.  Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.

Authors:  Nuray Aslan; Levi B Watkin; Anna Gil; Rabinarayan Mishra; Fransenio G Clark; Raymond M Welsh; Dario Ghersi; Katherine Luzuriaga; Liisa K Selin
Journal:  mBio       Date:  2017-12-05       Impact factor: 7.867

Review 6.  Human immunity against EBV-lessons from the clinic.

Authors:  Stuart G Tangye; Umaimainthan Palendira; Emily S J Edwards
Journal:  J Exp Med       Date:  2017-01-20       Impact factor: 14.307

Review 7.  The Role of Dendritic Cells in Immune Control and Vaccination against -Herpesviruses.

Authors:  Christian Münz
Journal:  Viruses       Date:  2019-12-05       Impact factor: 5.048

8.  Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy.

Authors:  Katerina Zachova; Petr Kosztyu; Josef Zadrazil; Karel Matousovic; Karel Vondrak; Petr Hubacek; Bruce A Julian; Zina Moldoveanu; Zdenek Novak; Klara Kostovcikova; Milan Raska; Jiri Mestecky
Journal:  Front Immunol       Date:  2020-02-28       Impact factor: 7.561

Review 9.  Immune Control and Vaccination against the Epstein-Barr Virus in Humanized Mice.

Authors:  Christian Münz
Journal:  Vaccines (Basel)       Date:  2019-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.